Federal Budget fallout
The 2013 Federal Budget has come down with cuts and pardons spread across the board for science, research, industry and education. [+]
10 commandments for next-gen sequencing
Geneticist Dan Koboldt from the Genome Institute at Washington University in St Louis gives his decalogue on next-generation sequencing. [+]
Phosphagenics and US agency target cow infection
Phosphagenics (ASX:POH) and a US Department of Agriculture research agency will jointly formulate and test products aimed at fighting the bacterial infection mastitis in... [+]
AusBiotech secures Australian first with world brain mapping congress
AusBiotech is pleased to announce that the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) will be held in Australia for the first time... [+]
Starpharma dendrimer effective against adenovius
Starpharma (ASX:SPL) said its lead dendrimer candidate has shown potential as the first treatment for adenovirus, the primary cause of viral conjunctivitis. [+]
Federal Budget fallout
The 2013 Federal Budget has come down with cuts and pardons spread across the board for science, research, industry and education. [+]
> Posted in Health & medical on 15 May, 201310 commandments for next-gen sequencing
Geneticist Dan Koboldt from the Genome Institute at Washington University in St Louis gives his decalogue on next-generation sequencing. [+]
> Posted in Molecular biology on 15 May, 2013Phosphagenics and US agency target cow infection
Phosphagenics (ASX:POH) and a US Department of Agriculture research agency will jointly formulate and test products aimed at fighting the bacterial infection mastitis in... [+]
> Posted in Biotechnology on 15 May, 2013AusBiotech secures Australian first with world brain mapping congress
AusBiotech is pleased to announce that the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) will be held in Australia for the first time... [+]
> Posted in Biotechnology on 14 May, 2013Starpharma dendrimer effective against adenovius
Starpharma (ASX:SPL) said its lead dendrimer candidate has shown potential as the first treatment for adenovirus, the primary cause of viral conjunctivitis. [+]
> Posted in Biotechnology on 13 May, 2013Latest News
Revised code to benefit ASX-listed life science companies
The Minister for Technology, the Hon Gordon Rich-Phillips, yesterday joined forces with the... [+]
> Posted in BiotechnologyA simple step from ocean to land
The shape change required for animals to make the major evolutionary transition from ocean to... [+]
> Posted in Life sciencesNew spin-out company to develop nanoparticle drugs
A new spin-out company has been set up by the University of Western Australia to commercialise... [+]
> Posted in BiotechnologyPartnership in sleep-disordered breathing
The University of Sydney and ResMed have created a new partnership that will support research... [+]
> Posted in Health & medicalREVA appoints new managing director
Michel Vanbrabant will joint REVA Medical (ASX:RVA) as managing director to help the company... [+]
> Posted in Biotechnology- Google+
- RSS Feeds
Australian Life Scientist: The Magazine
The magazine for research professionals in the life science and biotech sector across Australia. Click for your FREE subscription